Literature DB >> 16282045

The long-term prognosis of tension-type headache.

James R Couch1.   

Abstract

Tension-type headache (TTH) is a very common problem that usually causes only minimal to moderate discomfort and little disability. If episodic TTH evolves to chronic TTH, then the morbidity in terms of discomfort, disability, and use of medication escalates dramatically. There are no long-term studies, but inferences can be made from population surveys. These suggest that episodic TTH occurs in 15% to 75% of the population, but 30% to 40% is the most common estimate. There is a modest increase in prevalence between the ages of 30 and 50 years and a decrease to 25% to 35% prevalence after the age of 60 years. TTH appears to remain a problem for most sufferers throughout their lives.

Entities:  

Mesh:

Year:  2005        PMID: 16282045     DOI: 10.1007/s11916-005-0024-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  29 in total

Review 1.  Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Authors:  Z Katsarava; H C Diener; V Limmroth
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons.

Authors:  S J Wang; H C Liu; J L Fuh; C Y Liu; K P Lin; H M Chen; C H Lin; P N Wang; L C Hsu; H C Wang; K N Lin
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

4.  Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.

Authors:  P Schnider; S Aull; C Baumgartner; A Marterer; C Wöber; K Zeiler; P Wessely
Journal:  Cephalalgia       Date:  1996-11       Impact factor: 6.292

5.  Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.

Authors:  G A PETERS; B T HORTON
Journal:  J Lab Clin Med       Date:  1950-12

6.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

7.  2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Authors:  R B Lipton; W F Stewart; R Cady; C Hall; S O'Quinn; T Kuhn; D Gutterman
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

8.  Classification of daily and near-daily headaches: field trial of revised IHS criteria.

Authors:  S D Silberstein; R B Lipton; M Sliwinski
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

Review 9.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

10.  A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache.

Authors:  W Pryse-Phillips; H Findlay; P Tugwell; J Edmeads; T J Murray; R F Nelson
Journal:  Can J Neurol Sci       Date:  1992-08       Impact factor: 2.104

View more
  3 in total

Review 1.  Tension-type headache in the elderly.

Authors:  Robert G Kaniecki
Journal:  Curr Pain Headache Rep       Date:  2006-12

2.  Tension-type Headache in the Elderly.

Authors:  Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

Review 3.  Future therapeutic perspectives for tension-type headache.

Authors:  Marc E Lenaerts
Journal:  Curr Pain Headache Rep       Date:  2007-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.